Sector revisions Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Pharmaceuticals

Market Closed - Nasdaq 21:00:00 06/02/2025 GMT 5-day change 1st Jan Change
278.25 USD +0.70% Intraday chart for Alnylam Pharmaceuticals, Inc. +0.39% +18.25%
Main competitors
Add to a list
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
30
26
24
21
27
19
24
20
19
26
22
22
25
21
19
15
18
17
17
Average 22
Weighted average by Cap. 23
Other Pharmaceuticals